Valuation : Jerusalem Pharmaceutical Co.

Market Cap 128M 128M 110M 104M 94.63M 177M 12.07B 178M 1.23B 477M 6.17B 480M 469M 20.28B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 117M 117M 101M 95M 86.56M 162M 11.04B 163M 1.12B 437M 5.65B 439M 429M 18.55B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
35.74%
Yield 2024
2.09%
Yield 2025 3.26%
Manager TitleAgeSince
Chief Executive Officer - 2013-06-30
Director of Finance/CFO - 2020-02-29
Chief Tech/Sci/R&D Officer - 1988-12-31
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%+0.14%+21.37%+72.78% 49.06B
+0.41%+0.49%+52.69%+119.28% 40.37B
-0.97%-3.88%+13.37%+84.21% 12.19B
-1.28%-1.78%-11.64%+12.58% 12.08B
+0.57%+0.95%+29.02%+153.11% 9.14B
+0.08%-4.12%+24.01%+43.45% 7.36B
-0.04%-0.04%+22.68%+222.92% 7.35B
+0.81%+1.38%+44.31%-10.54% 7.32B
-1.29%-1.78%-40.82%+14.36% 5.19B
Average -0.28%-0.33%+17.22%+79.13% 16.67B
Weighted average by Cap. -0.30%+0.35%+26.12%+86.10%

Financials

2024 2025
Net sales 39.82M 39.82M 34.35M 32.36M 29.49M 55.11M 3.76B 55.53M 383M 149M 1.92B 150M 146M 6.32B 48.95M 48.95M 42.22M 39.78M 36.24M 67.74M 4.62B 68.25M 471M 183M 2.36B 184M 180M 7.77B
Net income 5.04M 5.04M 4.35M 4.09M 3.73M 6.97M 476M 7.02M 48.47M 18.81M 243M 18.92M 18.5M 799M 10.18M 10.18M 8.78M 8.28M 7.54M 14.09M 962M 14.2M 97.98M 38.02M 492M 38.24M 37.4M 1.62B
Net Debt -10.32M -10.32M -8.9M -8.39M -7.64M -14.29M -975M -14.39M -99.31M -38.54M -499M -38.76M -37.91M -1.64B -10.9M -10.9M -9.4M -8.86M -8.07M -15.08M -1.03B -15.19M -105M -40.69M -526M -40.92M -40.02M -1.73B
Logo Jerusalem Pharmaceutical Co.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
-